Expression of ras oncogene product and EGF receptor in cervical squamous cell carcinomas and its relationship to lymph node involvement
- 28 February 1991
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 40 (2) , 147-151
- https://doi.org/10.1016/0090-8258(91)90107-g
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Clinical implications of the epidermal growth factor receptor in the squamous cell carcinoma of the uterine cervixGynecologic Oncology, 1989
- The Molecular Genetics of CancerScience, 1987
- Structure of the human and murine R-ras genes, novel genes closely related to ras proto-oncogenesCell, 1986
- Alterations of myc , myb , and ras Ha Proto-Oncogenes In Cancers Are Frequent and Show Clinical CorrelationScience, 1986
- Biochemical properties of normal and oncogenic ras p21Trends in Biochemical Sciences, 1985
- Monoclonal antibodies define differential ras gene expression in malignant and benign colonic diseasesNature, 1984
- Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequencesNature, 1984
- Oncogenes and Cancer: The p21rasGenesCancer Investigation, 1984
- A cellular oncogene (c-Ki-ras) is amplified, overexpressed, and located within karyotypic abnormalities in mouse adrenocortical tumour cellsNature, 1983
- A point mutation is responsible for the acquisition of transforming properties by the T24 human bladder carcinoma oncogeneNature, 1982